Please use this identifier to cite or link to this item:
Title: Risk factors for potential drug-drug interactions in patients with pneumonia
Authors: Jankovic, Slobodan
Zaric R.
Stojadinovic M.
Lazic Z.
Cekerevac, Ivan
Susa R.
Journal: International Journal of Clinical Pharmacology and Therapeutics
Issue Date: 1-Jan-2021
Abstract: © 2021 Dustri-Verlag Dr. K. Feistle Objective: The goal of our study was to discover and analyze possible risk factors for and possible protective factors against the occurrence of potential drug-drug interactions (pDDIs) in a hospitalized patient with community-acquired pneumonia. Materials and methods: The central outcome was the incidence of pDDIs in patients with community-acquired pneumonia checked by Lexicomp and Micromedex interaction checkers. Results. The most severe pDDIs (Consider therapy modification D/ Avoid combination X/Major/Contraindicated) were found in 19 (20%) and 54 (58%) patients, according to Lexicomp and Micromedex, respectively. Patients with community-acquired pneumonia who were older, smokers, and with more prescribed drugs by more than a few independent prescribers had a higher risk to experience pDDIs. Possible protective factors were longer length of hospitalization, transfer from the Emergency Department, antiarrhythmic drugs as well as an anticoagulant therapy. Conclusion: In conclusion, community-acquired pneumonia patients with the above-mentioned factors should have their treatment more deeply monitored for pDDIs.
Type: Article
DOI: 10.5414/CP203822
ISSN: 09461965
SCOPUS: 85099008141
Appears in Collections:Faculty of Medical Sciences, Kragujevac
[ Google Scholar ]

Page views(s)


Files in This Item:
File Description SizeFormat 
  Restricted Access
29.86 kBAdobe PDFThumbnail
View/Open Request a copy

Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.